5 completed, 5 recruiting. 10 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 5, Recruiting 5 |
| Phase 2 | 6 | Recruiting 4, Completed 2 |
Follow TMS: new trials by email Literature Review of TMS trials Research Report on TMS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder Sham iTBS, TMS, D-cycloserine - Major Depression, Healthy Participants | Phase 1 / Phase 2 | Recruiting | Mclean Hospital | 100 | 2026-10-01 | 2026-10-30 |
| A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder TMS, D-Cycloserine (DCS) - Borderline Personality Disorder (BPD) | Phase 1 / Phase 2 | Recruiting | Mclean Hospital | 20 | 2026-06-10 | 2026-08-05 |
| Psilocybin Brain Stimulation and Imaging Pilot Study Psilocybin 25 mgs, TMS - Healthy Volunteers | Phase 1 | Completed | Johns Hopkins University | 10 | 2025-04-18 | 2026-08-07 |
| Pharmacologic Augmentation of TMS for Depression With D-serine TMS, D-serine, Placebo - Depression | Phase 1 | Recruiting | Mclean Hospital | 60 | 2025-04-01 | 2026-05-15 |
| Dual-target iTBS for Youth With ADHD TMS - ADHD | Phase 1 / Phase 2 | Recruiting | Shanghai Mental Health Center | 15 | 2025-01-01 | 2025-07-24 |
| Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD) TMS, Transcranial Magnetic Stimulation Sham - Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease | Phase 1 / Phase 2 | Recruiting | University of California, Los Angeles | 54 | 2024-10-17 | 2026-09-04 |
| Use of MRI and cTBS for Catatonia in Autism Continuous Theta Burst in Transcranial Magnetic Stimulation - Autism Spectrum Disorder, Catatonia | Phase 1 | Completed | Vanderbilt University Medical Center | 26 | 2023-08-23 | 2025-12-31 |
| Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Rituximab, Conditioning chemotherapy, TMS - Myelodysplastic Syndromes, Hodgkin's Lymphoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 2015-09-24 | 2025-09-30 |
| Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System Rituximab, Cyclosporine, Allogenic stem cell transplant (ASCT) - Myelodysplastic Syndrome, Hodgkin's Lymphoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 92 | 2007-10-30 | 2019-03-05 |
| Effects of Direct Current Brain Stimulation on Cognition TMS, EEG - Electrical Stimulation of the Brain | Phase 1 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 170 | 2002-11-01 | 2008-03-04 |
Depression (2) · Hodgkin Disease (2) · Leukemia (2) · Lymphoma (2) · Multiple Myeloma (2) · Myelodysplastic Syndromes (2) · Alzheimer Disease (1) · Attention Deficit Disorder with Hyperactivity (1) · Autism Spectrum Disorder (1) · Borderline Personality Disorder (1) · Catatonia (1) · Dementia (1) · Depressive Disorder, Major (1) · Intellectual Disability (1) · Lymphoma, Non-Hodgkin (1)
Mclean Hospital (3) · National Cancer Institute (NCI) (2) · Johns Hopkins University (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Shanghai Mental Health Center (1) · University of California, Los Angeles (1) · Vanderbilt University Medical Center (1)
United States (9) · China (1)
Alain Mina, M.D. (1) · Ceyda Sayali, PhD (1) · Jenna M Traynor, PhD (1) · Joshua Brown, MD, PhD (1) · Joshua C Brown, MD, PhD (1) · Kerry Ressler, MD, PhD (1) · Michael Leuchter, MD, MSc (1) · Steven Z Pavletic, M.D. (1)
PMID 32785680, PMID 38669315, PMID 40065917, PMID 40331908, PMID 42207275
K23AG097987 (1)